开立医疗
(300633)
| 流通市值：52.65亿 | | | 总市值：85.99亿 |
| 流通股本：2.60亿 | | | 总股本：4.25亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 480,719,375.08 | 2,308,908,666.51 | 1,459,311,230.15 | 964,264,625 |
| 营业总成本 | 523,253,650.33 | 2,183,569,025.01 | 1,499,658,882.65 | 955,582,429.16 |
| 其他经营收益 | | | | |
| 营业利润 | -16,811,436.34 | 165,282,780.51 | 9,591,435.58 | 34,472,560.48 |
| 利润总额 | -16,681,991.68 | 164,190,989.93 | 8,957,251.43 | 34,808,519.65 |
| 净利润 | -11,609,434.43 | 197,280,077.3 | 33,511,062.11 | 47,030,261.68 |
| 每股收益 | | | | |
| 其他综合收益 | 2,090,055.92 | -3,135,975.42 | 9,759,243.34 | -3,848,775.41 |
| 综合收益总额 | -9,519,378.51 | 194,144,101.88 | 43,270,305.45 | 43,181,486.27 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,703,428,761.05 | 2,816,015,503.63 | 2,673,062,414.67 | 2,604,158,805.18 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,595,624,830.49 | 1,590,295,354.13 | 1,442,953,795.86 | 1,413,611,125.95 |
| 资产总计 | 4,299,053,591.54 | 4,406,310,857.76 | 4,116,016,210.53 | 4,017,769,931.13 |
| 流动负债: | | | | |
| 流动负债合计 | 914,129,068.79 | 1,020,168,173.47 | 880,344,233.44 | 788,048,411.4 |
| 非流动负债: | | | | |
| 非流动负债合计 | 121,520,546.54 | 123,652,199.77 | 116,523,459.73 | 114,207,812.55 |
| 负债合计 | 1,035,649,615.33 | 1,143,820,373.24 | 996,867,693.17 | 902,256,223.95 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,263,403,976.21 | 3,262,490,484.52 | 3,119,148,517.36 | 3,115,513,707.18 |
| 股东权益合计 | 3,263,403,976.21 | 3,262,490,484.52 | 3,119,148,517.36 | 3,115,513,707.18 |
| 负债和股东权益合计 | 4,299,053,591.54 | 4,406,310,857.76 | 4,116,016,210.53 | 4,017,769,931.13 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 632,208,482.37 | 2,667,234,472.68 | 1,620,769,293.86 | 1,085,584,203.39 |
| 经营活动现金流出小计 | 771,992,711.22 | 2,715,394,038.33 | 2,001,741,353.86 | 1,335,883,536.41 |
| 经营活动产生的现金流量净额 | -139,784,228.85 | -48,159,565.65 | -380,972,060 | -250,299,333.02 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 448,306,476.84 | 790,383,391.94 | 685,529,722.35 | 655,974,893.76 |
| 投资活动现金流出小计 | 233,619,318.35 | 998,841,842.87 | 359,981,279.26 | 286,844,363.48 |
| 投资活动产生的现金流量净额 | 214,687,158.49 | -208,458,450.93 | 325,548,443.09 | 369,130,530.28 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 28,549,550.39 | 238,642,840.51 | 245,292,590.89 | 142,916,002.42 |
| 筹资活动现金流出小计 | 66,506,142.08 | 329,057,267.65 | 344,117,242.47 | 318,536,693.98 |
| 筹资活动产生的现金流量净额 | -37,956,591.69 | -90,414,427.14 | -98,824,651.58 | -175,620,691.56 |
| 汇率变动对现金及现金等价物的影响 | -10,187,794.59 | 2,891,504.89 | 378,972.51 | 727,637.48 |
| 现金及现金等价物净增加额 | 26,758,543.36 | -344,140,938.83 | -153,869,295.98 | -56,061,856.82 |
| 期末现金及现金等价物余额 | 1,205,179,377.3 | 1,178,420,833.94 | 1,368,692,476.79 | 1,466,499,915.95 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -344,140,938.83 | - | -56,061,856.82 |
最新报告期：2026-05-25| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 郑辰,李婵娟,陈俊威 | 0.85 | 0.99 | 1.16 | 2026-05-25 |
| 中信建投 | 朱琪璋,李虹达,王在存,贺菊颖 | 0.74 | 1.03 | 1.34 | 2026-05-21 |
| 中信建投 | 朱琪璋,李虹达,王在存,贺菊颖 | 0.74 | 1.03 | 1.34 | 2026-05-20 |
| 中泰证券 | 祝嘉琦,谢木青 | 0.76 | 1.05 | 1.28 | 2026-05-18 |
| 兴业证券 | 孙媛媛,董晓洁,黄翰漾 | 0.80 | 1.04 | 1.30 | 2026-05-18 |